Initial Statement of Beneficial Ownership (3)

Date : 02/11/2019 @ 11:42PM
Source : Edgar (US Regulatory)
Stock : Synaptics Incorporated (SYNA)
Quote : 27.98  0.0 (0.00%) @ 12:58PM

Initial Statement of Beneficial Ownership (3)

FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

NOLAN KERMIT

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/7/2019 

3. Issuer Name and Ticker or Trading Symbol

SYNAPTICS Inc [SYNA]

(Last)        (First)        (Middle)

1251 MCKAY DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
See Remarks /

(Street)

SAN JOSE, CA 95131       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   56111   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)     (2) 8/3/2019   Common Stock   5109   (3) $25.50   D    
Employee Stock Option (Right to Buy)     (4) 8/2/2020   Common Stock   13000   $31.73   D    
Employee Stock Option (Right to Buy)     (5) 10/31/2019   Common Stock   1000   $23.16   D    
Employee Stock Option (Right to Buy)     (6) 1/28/2020   Common Stock   1000   $35.76   D    
Employee Stock Option (Right to Buy)     (7) 4/29/2020   Common Stock   1000   $42.57   D    
Employee Stock Option (Right to Buy)     (8) 8/5/2020   Common Stock   1000   $39.80   D    
Employee Stock Option (Right to Buy)     (9) 10/28/2020   Common Stock   744   $46.50   D    
Employee Stock Option (Right to Buy)     (10) 1/27/2021   Common Stock   744   $60.22   D    
Employee Stock Option (Right to Buy)     (11) 4/28/2021   Common Stock   744   $61.40   D    
Employee Stock Option (Right to Buy)     (12) 8/1/2021   Common Stock   745   $78.11   D    
Employee Stock Option (Right to Buy)     (13) 10/24/2021   Common Stock   408   $62.105   D    
Employee Stock Option (Right to Buy)     (14) 1/30/2022   Common Stock   408   $76.81   D    
Employee Stock Option (Right to Buy)     (15) 4/24/2022   Common Stock   408   $85.69   D    
Employee Stock Option (Right to Buy)     (16) 7/31/2022   Common Stock   408   $79.38   D    
Employee Stock Option (Right to Buy)     (17) 10/23/2022   Common Stock   1049   $89.29   D    
Employee Stock Option (Right to Buy)     (18) 1/23/2023   Common Stock   1050   $73.31   D    
Employee Stock Option (Right to Buy)     (19) 4/29/2023   Common Stock   1049   $71.55   D    
Employee Stock Option (Right to Buy)     (20) 7/23/2023   Common Stock   1050   $51.95   D    

Explanation of Responses:
(1)  Includes (i) 7,648 shares that were acquired upon delivery of vested deferred stock units, (ii) 17,531 shares underlying deferred stock units that are not yet vested and deliverable, and (iii) 1,354 shares released in connection with the vesting of performance-based market stock units granted on 12/13/17.
(2)  25% of the 18,000 shares subject to the option vested and became exercisable on the 12 month anniversary of the 7/27/09 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 27th day of each month thereafter until fully vested on 7/27/13.
(3)  Does not include 12,891 shares underlying the option that were previously exercised.
(4)  1/48th of the total number of shares subject to the option vested and became exercisable on the 2nd day of each month following the 8/02/10 date of grant until fully vested on 8/02/14.
(5)  1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the 10/31/12 date of grant until fully vested on 10/29/15.
(6)  1/36th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the 1/28/13 date of grant until fully vested on 1/28/16.
(7)  1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the 4/29/13 date of grant until fully vested on 4/29/16.
(8)  1/36th of the total number of shares subject to the option vested and became exercisable on the 5th day of each month following the 8/05/13 date of grant until fully vested on 8/05/16.
(9)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/28/13 date of grant until fully vested on 10/28/16.
(10)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/27/14 date of grant until fully vested on 1/27/17.
(11)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 4/28/14 date of grant until fully vested on 4/28/17.
(12)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 8/01/14 date of grant until fully vested on 8/01/17.
(13)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/24/14 date of grant until fully vested on 10/24/17.
(14)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/30/15 date of grant until fully vested on 1/30/18.
(15)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 4/24/15 date of grant until fully vested on 4/24/18.
(16)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 7/31/15 date of grant until fully vested on 7/31/18.
(17)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/23/15 date of grant until fully vested on 10/23/18.
(18)  1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/29/16 date of grant until fully vested on 1/29/19.
(19)  1/12th of the total number of shares subject to the option vested or shall vest and became exercisable or shall become exercisable each quarter following the 4/29/16 date of grant until fully vested on 4/29/19.
(20)  1/12th of the total number of shares subject to the option vested or shall vest and became exercisable or shall become exercisable each quarter following the 7/29/16 date of grant until fully vested on 7/29/19.

Remarks:
The reporting person is the Corporate Vice President, Chief Accounting Officer, and Interim Chief Financial Officer.

Exhibit List

Exhibit 24 - Limited Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
NOLAN KERMIT
1251 MCKAY DRIVE
SAN JOSE, CA 95131


See Remarks

Signatures
Kermit Nolan 2/11/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Synaptics Incorporated (NASDAQ:SYNA)
Historical Stock Chart

1 Year : From Jun 2018 to Jun 2019

Click Here for more Synaptics Incorporated Charts.

Synaptics Incorporated (NASDAQ:SYNA)
Intraday Stock Chart

Today : Tuesday 25 June 2019

Click Here for more Synaptics Incorporated Charts.

Latest SYNA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.